SCHEMBL24111007

SCHEMBL24111007

COc1cccc2nc(Nc3cccnc3)n(-c3ccccc3)c(=O)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
KMT2A Q03164 2/20 0.42
TSHR P16473 2/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
G6PD P11413 1/20 0.41
LMNA P02545 2/20 0.41
ALOX12 P18054 1/20 0.41
POLB P06746 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
RAD52 P43351 1/20 0.40
AHR P35869 1/20 0.40
ELANE P08246 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23958355 0.86 ALOX12 (0.46) KMT2AALOX12MAPTRAD52ELANE
SCHEMBL24110960 0.84 PIK3CD (0.44) KMT2AUSP2LMNAALOX12RAD52
SCHEMBL23958352 0.83 G6PD (0.44) ALDH1A1KMT2ATSHRMEN1USP2
SCHEMBL23958222 0.81 KIT (0.35) ALDH1A1KMT2ATSHRMEN1LMNA
SCHEMBL24110995 0.81 ALOX12 (0.57) KMT2AMEN1USP2G6PDALOX12
SCHEMBL24110979 0.79 CYP19A1 (0.52) ALDH1A1KMT2ATSHRMEN1USP2
SCHEMBL23958345 0.78 G6PD (0.53) ALDH1A1KMT2ATSHRMEN1USP2
SCHEMBL23958226 0.78 RAD52 (0.45) KMT2AUSP2ALOX12KDM4ERAB9A
SCHEMBL24110973 0.78 ALOX12 (0.47) KMT2AMEN1USP2G6PDALOX12
SCHEMBL29738614 0.78 PIK3CD (0.46) KMT2AALOX12POLBRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 ALDH1A1 1803/4885KMT2A 1451/4885TSHR 1043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.